Ratio de margen de beneficio operativo
desde 2005

Thermo Fisher Scientific Inc., ratio de margen de beneficio operativo, tendencias a largo plazocálculo

	Ratio de margen de beneficio operativo	=	100	×	Resultado de explotación¹	÷	Ingresos¹
31 dic 2024	17.11%	=	100	×	7,337)	÷	42,879)
31 dic 2023	16.00%	=	100	×	6,859)	÷	42,857)
31 dic 2022	18.69%	=	100	×	8,393)	÷	44,915)
31 dic 2021	25.57%	=	100	×	10,028)	÷	39,211)
31 dic 2020	24.19%	=	100	×	7,794)	÷	32,218)
31 dic 2019	17.99%	=	100	×	4,594)	÷	25,542)
31 dic 2018	15.53%	=	100	×	3,783)	÷	24,358)
31 dic 2017	14.19%	=	100	×	2,968)	÷	20,918)
31 dic 2016	13.40%	=	100	×	2,449)	÷	18,274)
31 dic 2015	13.77%	=	100	×	2,336)	÷	16,965)
31 dic 2014	14.82%	=	100	×	2,503)	÷	16,890)
31 dic 2013	12.30%	=	100	×	1,610)	÷	13,090)
31 dic 2012	11.85%	=	100	×	1,482)	÷	12,510)
31 dic 2011	10.62%	=	100	×	1,245)	÷	11,726)
31 dic 2010	11.72%	=	100	×	1,265)	÷	10,789)
31 dic 2009	10.38%	=	100	×	1,049)	÷	10,110)
31 dic 2008	11.71%	=	100	×	1,229)	÷	10,498)
31 dic 2007	10.00%	=	100	×	974)	÷	9,746)
31 dic 2006	6.38%	=	100	×	242)	÷	3,792)
31 dic 2005	10.01%	=	100	×	263)	÷	2,633)

¹ US$ en millones

Thermo Fisher Scientific Inc., ratio de margen de beneficio operativo, tendencias a largo plazo, comparación con los competidores

	Thermo Fisher Scientific Inc.	AbbVie Inc.	Amgen Inc.	Danaher Corp.	Gilead Sciences Inc.	Regeneron Pharmaceuticals Inc.	Vertex Pharmaceuticals Inc.
31 dic 2024	17.11%	16.22%	22.66%	20.37%	5.81%	28.10%	-2.11%
31 dic 2023	16.00%	23.49%	29.35%	21.77%	28.24%	30.85%	38.83%
31 dic 2022	18.69%	31.21%	38.57%	27.61%	27.17%	38.93%	48.23%
31 dic 2021	25.57%	31.89%	31.44%	25.35%	36.72%	55.67%	36.73%
31 dic 2020	24.19%	24.81%	37.70%	18.99%	16.72%	42.09%	46.03%
31 dic 2019	17.99%	39.03%	43.57%	18.25%	19.38%	28.10%	28.77%
31 dic 2018	15.53%	19.49%	45.55%	17.11%	37.83%	37.77%	20.84%
31 dic 2017	14.19%	33.99%	45.76%	16.48%	55.04%	35.41%	4.95%
31 dic 2016	13.40%	36.60%	44.74%	16.29%	58.87%	27.38%	0.58%
31 dic 2015	13.77%	32.97%	40.44%	16.87%	69.03%	30.51%	-45.23%
31 dic 2014	14.82%	17.09%	32.03%	17.23%	62.37%	29.74%	-119.30%
31 dic 2013	12.30%	30.14%	32.25%	17.13%	41.87%	36.11%	-74.54%
31 dic 2012	11.85%	31.65%	33.52%	17.33%	42.67%	33.20%	0.15%
31 dic 2011	10.62%	—	28.19%	16.27%	46.77%	-46.02%	8.07%
31 dic 2010	11.72%	—	37.82%	16.41%	53.62%	-21.23%	-485.51%
31 dic 2009	10.38%	—	38.37%	13.79%	54.55%	-19.54%	-602.63%
31 dic 2008	11.71%	—	35.50%	14.72%	52.68%	-37.67%	-263.65%
31 dic 2007	10.00%	—	27.81%	15.79%	57.98%	-91.55%	-210.94%
31 dic 2006	6.38%	—	27.71%	15.82%	-29.32%	-169.68%	-105.86%
31 dic 2005	10.01%	—	40.33%	15.84%	61.41%	-187.97%	-93.15%

Thermo Fisher Scientific Inc. (NYSE:TMO)